The kidney allocation system aims to distribute kidneys from deceased donors in an equitable and potential-life optimising manner. This is a difficult task, not least because intrinsic biological differences, such as a person's ABO blood type, influence the allocation. This paper begins by presenting a curious and undocumented empirical fact: candidates on the kidney transplant waitlist with blood types implying they will more rapidly be offered a kidney display lower pre-transplant survival. The paper investigates whether this difference in pre-transplant survival is due to biological, behavioural, or spurious selection. To that end, we promote a two-in-one randomization design which allows us to credibly fit our empirical setting within a dynamic potential outcomes framework. Using this framework, drawing from economic theory, and noting problematic financial and legal market incentives, the paper systematically evaluates different explanations for pre-transplant survival patterns. Our analysis establishes a small set of behavioural explanations which directly inform debates about how to reduce the excessive discard of viable kidneys in the US transplant market.
We use cookies to provide you with an optimal website experience. This includes cookies that are necessary for the operation of the site as well as cookies that are only used for anonymous statistical purposes, for comfort settings or to display personalized content. You can decide for yourself which categories you want to allow. Please note that based on your settings, you may not be able to use all of the site's functions.
Cookie settings
These necessary cookies are required to activate the core functionality of the website. An opt-out from these technologies is not available.
In order to further improve our offer and our website, we collect anonymous data for statistics and analyses. With the help of these cookies we can, for example, determine the number of visitors and the effect of certain pages on our website and optimize our content.